91 related articles for article (PubMed ID: 20164567)
21. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
[TBL] [Abstract][Full Text] [Related]
22. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
23. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y
Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061
[TBL] [Abstract][Full Text] [Related]
24. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
[TBL] [Abstract][Full Text] [Related]
26. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
[TBL] [Abstract][Full Text] [Related]
27. Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice.
Stahl T; Reimers C; Johne R; Schliebs R; Seeger J
Eur J Neurosci; 2006 Oct; 24(7):1923-34. PubMed ID: 17067295
[TBL] [Abstract][Full Text] [Related]
28. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
29. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM
Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111
[TBL] [Abstract][Full Text] [Related]
30. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
31. Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloid β proteins in amyloid precursor protein transgenic mice.
Fujiwara H; Takayama S; Iwasaki K; Tabuchi M; Yamaguchi T; Sekiguchi K; Ikarashi Y; Kudo Y; Kase Y; Arai H; Yaegashi N
Neuroscience; 2011 Apr; 180():305-13. PubMed ID: 21303686
[TBL] [Abstract][Full Text] [Related]
32. Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy.
Guo JP; Yu S; McGeer PL
J Alzheimers Dis; 2010; 19(4):1359-70. PubMed ID: 20061605
[TBL] [Abstract][Full Text] [Related]
33. Juzen-taiho-to, an herbal medicine, activates and enhances phagocytosis in microglia/macrophages.
Liu H; Wang J; Sekiyama A; Tabira T
Tohoku J Exp Med; 2008 May; 215(1):43-54. PubMed ID: 18509234
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow-derived macrophages from AβPP/PS1 mice are sensitized to the effects of inflammatory stimuli.
Barrett JP; Minogue AM; Jones RS; Ribeiro C; Kelly RJ; Lynch MA
J Alzheimers Dis; 2015; 44(3):949-62. PubMed ID: 25374107
[TBL] [Abstract][Full Text] [Related]
35. Effect of Naoling decoction on the expression of APP in hippocampal CA3 region in rats with synthetic Alzheimer's disease.
Zhong B; Wang Z; He M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):431-7. PubMed ID: 20543465
[TBL] [Abstract][Full Text] [Related]
36. Validation of the APP23 transgenic mouse model of Alzheimer's disease through evaluation of risperidone treatment on aggressive behaviour.
Vloeberghs E; Coen K; Van Dam D; De Deyn PP
Arzneimittelforschung; 2008; 58(6):265-8. PubMed ID: 18677967
[TBL] [Abstract][Full Text] [Related]
37. Manipulating phagocyte activity in Alzheimer's disease.
Combs CK
J Alzheimers Dis; 2010; 20(2):441-3. PubMed ID: 20182046
[No Abstract] [Full Text] [Related]
38. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease.
Mildner A; Schlevogt B; Kierdorf K; Böttcher C; Erny D; Kummer MP; Quinn M; Brück W; Bechmann I; Heneka MT; Priller J; Prinz M
J Neurosci; 2011 Aug; 31(31):11159-71. PubMed ID: 21813677
[TBL] [Abstract][Full Text] [Related]
39. Anti-angiogenic and immunomodulatory effect of the herbal medicine "Juzen-taiho-to" on malignant glioma.
Kamiyama H; Takano S; Ishikawa E; Tsuboi K; Matsumura A
Biol Pharm Bull; 2005 Nov; 28(11):2111-6. PubMed ID: 16272699
[TBL] [Abstract][Full Text] [Related]
40. [The effect of herbal medicines on the immunodeficient animals by injecting cancer chemotherapeutic agent-special reference to age related recovery of the function].
Li AL; Komatsu Y; Ono Y; Nakatani F; Nakashima K; Yamaguchi N
Kansenshogaku Zasshi; 1996 Jul; 70(7):717-26. PubMed ID: 8797307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
